{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:45:55Z","timestamp":1793317555703,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T00:00:00Z","timestamp":1517788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00198-018-4415-y","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T09:16:18Z","timestamp":1517822178000},"page":"759-767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry"],"prefix":"10.1007","volume":"29","author":[{"given":"W. D.","family":"Leslie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. N.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. T.","family":"Schousboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. E.","family":"Ensrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. V.","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Kanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"4415_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH Consensus Development Panel","year":"2001","unstructured":"Consensus Development Panel NIH (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785\u2013795","journal-title":"JAMA"},{"key":"4415_CR2","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00198-017-4009-0","volume":"28","author":"JA Kanis","year":"2017","unstructured":"Kanis JA, Cooper C, Rizzoli R et al (2017) Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporos Int 28:2023\u20132034","journal-title":"Osteoporos Int"},{"key":"4415_CR3","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1007\/s00198-017-4153-6","volume":"28","author":"S Williamson","year":"2017","unstructured":"Williamson S, Landeiro F, McConnell T et al (2017) Costs of fragility hip fractures globally: a systematic review and meta-regression analysis. Osteoporos Int 28:2791\u20132800","journal-title":"Osteoporos Int"},{"key":"4415_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","volume":"148","author":"C MacLean","year":"2008","unstructured":"MacLean C, Newberry S, Maglione M et al (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148:197\u2013213","journal-title":"Ann Intern Med"},{"key":"4415_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/1471-2474-12-209","volume":"12","author":"RB Hopkins","year":"2011","unstructured":"Hopkins RB, Goeree R, Pullenayegum E et al (2011) The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet Disord 12:209","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"4415_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-013-2409-3","volume":"25","author":"WD Leslie","year":"2014","unstructured":"Leslie WD, Lix LM (2014) Comparison between various fracture risk assessment tools. Osteoporos Int 25(1):1\u201321. \n                    https:\/\/doi.org\/10.1007\/s00198-013-2409-3","journal-title":"Osteoporos Int"},{"key":"4415_CR7","unstructured":"Kanis JA, on behalf of the World Health Organization Scientific Group. Assessment of osteoporosis at the primary health-care level. Technical Report. Accessible at \n                    http:\/\/www.shef.ac.uk\/FRAX\/pdfs\/WHO_Technical_Report.pdf\n                    \n                  . 2007. Published by the University of Sheffield"},{"key":"4415_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s001980070064","volume":"11","author":"JA Kanis","year":"2000","unstructured":"Kanis JA, Johnell O, Oden A et al (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11:669\u2013674","journal-title":"Osteoporos Int"},{"key":"4415_CR9","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/sj.bjc.6602102","volume":"91","author":"JM Satagopan","year":"2004","unstructured":"Satagopan JM, Ben-Porat L, Berwick M et al (2004) A note on competing risks in survival data analysis. Br J Cancer 91:1229\u20131235","journal-title":"Br J Cancer"},{"issue":"1","key":"4415_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"JA Kanis","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C et al (2016) A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25\u20130278. \n                    https:\/\/doi.org\/10.1007\/s11657-016-0278-z","journal-title":"Arch Osteoporos"},{"issue":"5","key":"4415_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00198-009-1026-7","volume":"21","author":"SK Sandhu","year":"2010","unstructured":"Sandhu SK, Nguyen ND, Center JR, Pocock NA, Eisman JA, Nguyen TV (2010) Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram. Osteoporos Int 21(5):863\u2013871. \n                    https:\/\/doi.org\/10.1007\/s00198-009-1026-7","journal-title":"Osteoporos Int"},{"issue":"jul03 5","key":"4415_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4120","volume":"349","author":"KE Ensrud","year":"2014","unstructured":"Ensrud KE, Taylor BC, Peters KW, Gourlay ML, Donaldson MG, Leslie WD, Blackwell TL, Fink HA, Orwoll ES, Schousboe J, for the Osteoporotic Fractures in Men (MrOS) Study Group (2014) Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study. BMJ 349(jul03 5):g4120. \n                    https:\/\/doi.org\/10.1136\/bmj.g4120","journal-title":"BMJ"},{"key":"4415_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00198-004-1756-5","volume":"16","author":"WD Leslie","year":"2005","unstructured":"Leslie WD, MacWilliam L, Lix L et al (2005) A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int 16:773\u2013782","journal-title":"Osteoporos Int"},{"issue":"1","key":"4415_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1385\/JCD:8:1:025","volume":"8","author":"WD Leslie","year":"2005","unstructured":"Leslie WD, Caetano PA, MacWilliam LR, Finlayson GS (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8(1):25\u201330. \n                    https:\/\/doi.org\/10.1385\/JCD:8:1:025","journal-title":"J Clin Densitom"},{"issue":"5","key":"4415_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s001980050093","volume":"8","author":"AC Looker","year":"1998","unstructured":"Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay R (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8(5):468\u2013489. \n                    https:\/\/doi.org\/10.1007\/s001980050093","journal-title":"Osteoporos Int"},{"issue":"3","key":"4415_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ III, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42(3):467\u2013475. \n                    https:\/\/doi.org\/10.1016\/j.bone.2007.11.001","journal-title":"Bone"},{"issue":"10","key":"4415_CR17","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, Leboff MS et al (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359\u20132381. \n                    https:\/\/doi.org\/10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"},{"issue":"3","key":"4415_CR18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00198-010-1464-2","volume":"22","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Lix LM, Langsetmo L, Berger C, Goltzman D, Hanley DA, Adachi JD, Johansson H, Oden A, McCloskey E, Kanis JA (2011) Construction of a FRAX((R)) model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int 22(3):817\u2013827. \n                    https:\/\/doi.org\/10.1007\/s00198-010-1464-2","journal-title":"Osteoporos Int"},{"issue":"11","key":"4415_CR19","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1002\/jbmr.123","volume":"25","author":"WD Leslie","year":"2010","unstructured":"Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, Manitoba Bone Density Program (2010) Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res 25(11):2350\u20132358. \n                    https:\/\/doi.org\/10.1002\/jbmr.123","journal-title":"J Bone Miner Res"},{"key":"4415_CR20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00198-010-1465-1","volume":"22","author":"LA Fraser","year":"2011","unstructured":"Fraser LA, Langsetmo L, Berger C et al (2011) Fracture prediction and calibration of a Canadian FRAX(R) tool: a population-based report from CaMos. Osteoporos Int 22:829\u2013837","journal-title":"Osteoporos Int"},{"key":"4415_CR21","doi-asserted-by":"publisher","first-page":"i6755","DOI":"10.1136\/bmj.i6755","volume":"356","author":"N Dagan","year":"2017","unstructured":"Dagan N, Cohen-Stavi C, Leventer-Roberts M et al (2017) External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study. BMJ 356:i6755. \n                    https:\/\/doi.org\/10.1136\/bmj.i6755.:i6755","journal-title":"BMJ"},{"key":"4415_CR22","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. (eds) (2005) Guidelines for ATC classification and DDD assignment. Oslo"},{"issue":"6","key":"4415_CR23","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/jbmr.1582","volume":"27","author":"WD Leslie","year":"2012","unstructured":"Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, for the Manitoba Bone Density Program (2012) Does osteoporosis therapy invalidate FRAX for fracture prediction? J Bone Miner Res 27(6):1243\u20131251. \n                    https:\/\/doi.org\/10.1002\/jbmr.1582","journal-title":"J Bone Miner Res"},{"issue":"1","key":"4415_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1210\/jc.2006-1415","volume":"92","author":"WD Leslie","year":"2007","unstructured":"Leslie WD, Tsang JF, Caetano PA, Lix LM, Manitoba Bone Density Program (2007) Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab 92(1):77\u201381. \n                    https:\/\/doi.org\/10.1210\/jc.2006-1415","journal-title":"J Clin Endocrinol Metab"},{"issue":"6 Suppl","key":"4415_CR25","first-page":"JS10","volume":"37","author":"NP Roos","year":"1999","unstructured":"Roos NP, Shapiro E (1999) Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system. Med Care 37(6 Suppl):JS10\u2013JS14","journal-title":"Med Care"},{"issue":"2","key":"4415_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00198-012-2051-5","volume":"24","author":"WD Leslie","year":"2013","unstructured":"Leslie WD, Lix LM, Wu X (2013) Competing mortality and fracture risk assessment. Osteoporos Int 24(2):681\u2013688. \n                    https:\/\/doi.org\/10.1007\/s00198-012-2051-5","journal-title":"Osteoporos Int"},{"key":"4415_CR27","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","volume":"312","author":"D Marshall","year":"1996","unstructured":"Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254\u20131259","journal-title":"BMJ"},{"issue":"11","key":"4415_CR28","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1359\/jbmr.2003.18.11.1947","volume":"18","author":"KL Stone","year":"2003","unstructured":"Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS, Nevitt MC, Cummings SR, Osteoporotic Fractures Research Group (2003) BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 18(11):1947\u20131954. \n                    https:\/\/doi.org\/10.1359\/jbmr.2003.18.11.1947","journal-title":"J Bone Miner Res"},{"issue":"1","key":"4415_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","volume":"34","author":"SC Schuit","year":"2004","unstructured":"Schuit SC, van der Klift M, Weel AE et al (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone 34(1):195\u2013202. \n                    https:\/\/doi.org\/10.1016\/j.bone.2003.10.001","journal-title":"Bone"},{"issue":"10","key":"4415_CR30","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","volume":"164","author":"ES Siris","year":"2004","unstructured":"Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164(10):1108\u20131112. \n                    https:\/\/doi.org\/10.1001\/archinte.164.10.1108","journal-title":"Arch Intern Med"},{"issue":"11","key":"4415_CR31","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1002\/jbmr.1759","volume":"27","author":"WD Leslie","year":"2012","unstructured":"Leslie WD, Rubin MR, Schwartz AV, Kanis JA (2012) Type 2 diabetes and bone. J Bone Miner Res 27(11):2231\u20132237. \n                    https:\/\/doi.org\/10.1002\/jbmr.1759","journal-title":"J Bone Miner Res"},{"issue":"3","key":"4415_CR32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jocd.2015.06.013","volume":"18","author":"JA Shepherd","year":"2015","unstructured":"Shepherd JA, Schousboe JT, Broy SB, Engelke K, Leslie WD (2015) Executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD. J Clin Densitom 18(3):274\u2013286. \n                    https:\/\/doi.org\/10.1016\/j.jocd.2015.06.013","journal-title":"J Clin Densitom"},{"key":"4415_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/1471-2458-12-301","volume":"12","author":"LM Lix","year":"2012","unstructured":"Lix LM, Azimaee M, Osman BA et al (2012) Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health 12:301","journal-title":"BMC Public Health"},{"key":"4415_CR34","doi-asserted-by":"crossref","unstructured":"O'Donnell S (2013) Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study. Arch Osteoporos 8(143)","DOI":"10.1007\/s11657-013-0143-2"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-018-4415-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4415-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4415-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:43:17Z","timestamp":1549327397000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-018-4415-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["4415"],"URL":"https:\/\/doi.org\/10.1007\/s00198-018-4415-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,5]]},"assertion":[{"value":"1 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Health Research Ethics Board for the University of Manitoba.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Suzanne Morin: Research Grants: Amgen, Merck.Eugene McCloskey: Nothing to declare for FRAX and the context of this paper, but numerous ad hoc consultancies\/speaking honoraria and\/or research funding from Amgen, Bayer, General Electric, GSK, Hologic, Lilly, Merck Research Labs, Novartis, Novo Nordisk, Nycomed, Ono, Pfizer, ProStrakan, Roche, Sanofi-Aventis, Servier, Tethys, UBS, and Warner-Chilcott.John A. Kanis: Grants from Amgen, grants from Lilly, non-financial support from Medimaps, grants from Unigene, non-financial support from Asahi, and grants from Radius Health, outside the submitted work. Dr. Kanis is the architect of FRAX but has no financial interest. Governmental and NGOs: National Institute for health and clinical Excellence (NICE), UK; International Osteoporosis Foundation; INSERM, France; Ministry of Public Health, China; Ministry of Health, Australia; Ministry of Health, Abu Dhabi; National Osteoporosis Guideline Group, UK; WHO.William Leslie, Sumit Majumdar, Lisa Lix, H. Johansson, John T. Schousboe, Kristine E. Ensrud: None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}